Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant
Clinical trial NCT01473810 · COMPLETED
Trial details
- NCT number
- NCT01473810
- Sponsor
- Oslo University Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-03-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.